The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
CA 2362524 A1 · Owner: Komurian-Pradel, Florence · Inventors: Paranhos-Baccala, Glaucia; Perron, Herve; Komurian-Pradel, Florence
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a nucleotide fragment of a LTR-RU5 region comprising a nucleotide sequence which encodes the expression of a protein wherein said , protein comprises a peptide sequence selected from SEQ ID NO: 2 SEQ ID NO: 3 , and SEQ ID NO: 4, and a complementary nucleotide fragment; a probe and a primer hybridizing with said fragment; a protein encoded by said fragment and a polypeptide; an antibody directed against said protein or said polypeptide; and a process for detecting the presence of MSRV-1 retrovirus using a probe or an antibody of the invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 15, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 15, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 15, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.